The intersection of virus detection and antiviral drug development is pivotal in pre-emptively identifying and mitigating viral outbreaks. Rigorous epidemiological surveillance enables early detection of emergent viral threats, facilitating the implementation of targeted intervention strategies and reshaping the landscape of disease prevention. The advancement in antiviral drug research is paramount, particularly in contexts where vaccines are insufficient. Highlighting the enhancement of virus detection methodologies and antiviral drug development can fortify our defences against viral threats, offering a robust framework for anticipating and managing emerging viral diseases across both human and animal populations, including zoonotic infections. Despite significant strides in antiviral drug development, researchers face persistent challenges such as drug resistance, limited efficacy, and safety concerns. This Research Topic seeks to foster collaboration and knowledge exchange among scientists to accelerate progress in viral disease detection and drug treatment, addressing these critical challenges.
This Research Topic aims to catalyze innovation in the fight against emerging viral diseases by encouraging submissions that cover original research, reviews, and perspectives. The focus spans the epidemiology, detection methods, and development of antiviral drugs for human and animal viral diseases, with a particular emphasis on zoonotic diseases. As the global community contends with the ongoing threat of infectious diseases, the continuous recombination and evolution of pathogens across human and animal sources underscore the urgent need for comprehensive monitoring and genetic analysis of viral pathogens. Understanding the genetic variations and evolutionary patterns of these viruses is essential for devising effective strategies to curb their spread and mitigate their impact on public health.
This Research Topic invites contributions that delve into various aspects of viral epidemiology, detection methods, and antiviral drug development. Researchers are encouraged to submit original research, reviews, and perspectives. The specific themes include, but are not limited to:
o Establishment of epidemiological investigations and detection methods for human and animal viruses, pet viruses, and zoonotic pathogens.
o Molecular tracing and genetic variation analysis.
o Study of codon usage bias in human and animal viral genomes.
o Screening of antiviral drugs and research on their mechanisms of action.
o Investigation of traditional Chinese medicine applications in antiviral therapies for zoonotic diseases.
Keywords:
cross species infection, antiviral drugs, zoonotic diseases, genetic evolution, molecular epidemiology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The intersection of virus detection and antiviral drug development is pivotal in pre-emptively identifying and mitigating viral outbreaks. Rigorous epidemiological surveillance enables early detection of emergent viral threats, facilitating the implementation of targeted intervention strategies and reshaping the landscape of disease prevention. The advancement in antiviral drug research is paramount, particularly in contexts where vaccines are insufficient. Highlighting the enhancement of virus detection methodologies and antiviral drug development can fortify our defences against viral threats, offering a robust framework for anticipating and managing emerging viral diseases across both human and animal populations, including zoonotic infections. Despite significant strides in antiviral drug development, researchers face persistent challenges such as drug resistance, limited efficacy, and safety concerns. This Research Topic seeks to foster collaboration and knowledge exchange among scientists to accelerate progress in viral disease detection and drug treatment, addressing these critical challenges.
This Research Topic aims to catalyze innovation in the fight against emerging viral diseases by encouraging submissions that cover original research, reviews, and perspectives. The focus spans the epidemiology, detection methods, and development of antiviral drugs for human and animal viral diseases, with a particular emphasis on zoonotic diseases. As the global community contends with the ongoing threat of infectious diseases, the continuous recombination and evolution of pathogens across human and animal sources underscore the urgent need for comprehensive monitoring and genetic analysis of viral pathogens. Understanding the genetic variations and evolutionary patterns of these viruses is essential for devising effective strategies to curb their spread and mitigate their impact on public health.
This Research Topic invites contributions that delve into various aspects of viral epidemiology, detection methods, and antiviral drug development. Researchers are encouraged to submit original research, reviews, and perspectives. The specific themes include, but are not limited to:
o Establishment of epidemiological investigations and detection methods for human and animal viruses, pet viruses, and zoonotic pathogens.
o Molecular tracing and genetic variation analysis.
o Study of codon usage bias in human and animal viral genomes.
o Screening of antiviral drugs and research on their mechanisms of action.
o Investigation of traditional Chinese medicine applications in antiviral therapies for zoonotic diseases.
Keywords:
cross species infection, antiviral drugs, zoonotic diseases, genetic evolution, molecular epidemiology
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.